Similar articles

• Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.

  Goldrath AW, Barber L, Chen KE, Alters SE. Goldrath AW, et al. J Autoimmun. 1995 Apr;8(2):209-20. doi: 10.1006/jaut.1995.0016. J Autoimmun. 1995. PMID: 7612149
• Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.

  Toyoda H, Formby B. Toyoda H, et al. Bioessays. 1998 Sep;20(9):750-7. doi: 10.1002/(SICI)1521-1878(199809)20:9<750::AID-BIES8>3.0.CO;2-K. Bioessays. 1998. PMID: 9819564 Review.
• A defect in central tolerance in NOD mice.

  Kishimoto H, Sprent J. Kishimoto H, et al. Nat Immunol. 2001 Nov;2(11):1025-31. doi: 10.1038/ni726. Nat Immunol. 2001. PMID: 11668341
• T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.

  Martignat L, Feve B, Ouary M, Pogu S, Charbonnel B, Saï P. Martignat L, et al. J Autoimmun. 1993 Dec;6(6):753-69. doi: 10.1006/jaut.1993.1062. J Autoimmun. 1993. PMID: 8155255
• Genetic and immunological basis of autoimmune diabetes in the NOD mouse.

  Yoshida K, Kikutani H. Yoshida K, et al. Rev Immunogenet. 2000;2(1):140-6. Rev Immunogenet. 2000. PMID: 11324686 Review.